EGFR Tyrosine Kinase Inhibitor Sequencing Revisited: From the Revival of Old Tools to the Integration of New Agents
- PMID: 36031285
- DOI: 10.1016/j.jtho.2022.07.005
EGFR Tyrosine Kinase Inhibitor Sequencing Revisited: From the Revival of Old Tools to the Integration of New Agents
Comment on
-
POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLC.J Thorac Oncol. 2022 Sep;17(9):1109-1121. doi: 10.1016/j.jtho.2022.06.004. Epub 2022 Jun 24. J Thorac Oncol. 2022. PMID: 35760287 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
